Likelihood of prostate cancer based on prostate-specific antigen density by MRI: Retrospective analysis

Journal of Computer Assisted Tomography

Volumn 26, Issue 3, 2002, Pages 432-437

  Mueller Lisse, Ullrich G ^a   Mueller Lisse, Ulrike L ^a   Haller, Steffen ^a   Schneede, Peter ^a   Scheidler, Juergen E ^a   Schmeller, Nicolaus ^a   Hofstetter, Alfons G ^a   Reiser, Maximilian F ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Magnetic resonance imaging; Prostate; Prostate specific antigen; Prostate specific antigen density; Transitional zone

Indexed keywords

ANTIGENS; BIOPSY; DISEASES; UROLOGY;

BENIGN PROSTATIC HYPERTROPHY; CONFIDENCE INTERVAL; ODD RATIOS; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; PROSTATE-SPECIFIC ANTIGEN DENSITY; TRANSITIONAL ZONE;

MAGNETIC RESONANCE IMAGING;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 0036260001     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200205000-00020     Document Type: Article

References (27)

1. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves
2. Prostate specific antigen density of the transition zone: A new effective parameter for prostate cancer prediction
3. Transition zone prostate specific antigen density: Lack of use in prediction of prostatic carcinoma
4. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography
5. Postoperative MRI in patients undergoing interstitial laser coagulation thermotherapy of benign prostatic hyperplasia
6. Transrectal ultrasound examination of the prostate: Complications and acceptance by patients
7. Complications of ultrasound guided transperineal puncture biopsy of the prostate
8. Multiple transrectal ultrasound guided prostatic biopsies: Morbidity and tolerance
9. Morbidity with contemporary prostate biopsy
10. Complications following combined transrectal aspiration and cor biopsy of the prostate
11. Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores
12. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: Evaluation of complication rates and risk factors within a population based screening program
13. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature
14. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels
15. Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (gamma-seminoprotein)/PSA ratio in the diagnosis of prostate cancer in patients with intermediate PSA levels
16. Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer
17. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations
18. Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging
19. Reassessment of nonplanimetric transrectal ultrasound prostate volume estimates
20. Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume
21. Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique
22. A comparative analysis of monoclonal assays for the determination of PSA: Radioimmunometric assay (ELSA) vs. microparticle immunoenzyme assay (MEIA)
23. Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
24. Prospective evaluation of prostate cancer detection by prostate-specific antigen-related parameters
25. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges
26. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
27. Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia